Description
Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 5/02: Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
A61P 5/02
Sub-Class
Stats
- 29 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- 21 Total Patent Owners
- 172 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 11987648 | Cyclohexapeptides as selective somatostatin SST5 receptor agonists | Oct 14, 19 | May 21, 24 | Heptares Therapeutics Limited |
| 11530239 | Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor | Mar 04, 21 | Dec 20, 22 | The Board of Regents of the University of Oklahoma |
| 10975124 | Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor | Feb 13, 19 | Apr 13, 21 | The Board of Regents of the University of Oklahoma |
| 10709744 | Probiotic biofilm suppositories | Mar 28, 19 | Jul 14, 20 | MYBIOTICS PHARMA LTD. |
| 9987359 | Subcutaneous injection product for cattle for inducing superovulation | May 23, 14 | Jun 05, 18 | Kyoritsu Seiyaku Corporation |
| 9937264 | Glycosylated polypeptide and drug composition containing said polypeptide | Jul 08, 16 | Apr 10, 18 | Glytech Inc. |
| 9802996 | Glycosylated polypeptide and drug composition containing said polypeptide | Jul 19, 16 | Oct 31, 17 | GLYTECH, INC. |
| 9724380 | Method and compositions for synchronizing time of insemination in gilts | Nov 27, 13 | Aug 08, 17 | JBS UNITED ANIMAL HEALTH II LLC |
| 9441024 | Glycosylated polypeptide and drug composition containing said polypeptide | Sep 03, 12 | Sep 13, 16 | GLYTECH, INC. |
| 9422357 | Glycosylated polypeptide and drug composition containing said polypeptide | Sep 03, 12 | Aug 23, 16 | GLYTECH, INC. |
| 9393288 | Methods of treating diseases associated with PPARγ | Mar 12, 13 | Jul 19, 16 | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE |
| 9382306 | Octapeptide compounds derived from somatostatin and the therapeutic use thereof | Sep 29, 09 | Jul 05, 16 | COMMISSARIAT A L'ENERGIE ATOMIQUE, IPSEN PHARMA S.A.S., LE CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (CNRS), |
| 9333234 | Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors | Apr 10, 13 | May 10, 16 | NOVARTIS AG |
| 9149510 | Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes | Apr 30, 13 | Oct 06, 15 | NOVARTIS AG |
| 9040482 | Octapeptide compounds and therapeutic use thereof | Jun 21, 11 | May 26, 15 | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, COMMISSARIAT A L'ENERGIE ATOMIQUE, IPSEN PHARMA S.A.S., |
| 8916681 | Compound, use and method | Oct 08, 08 | Dec 23, 14 | MEDICAL RESEARCH COUNCIL |
| 8877225 | Controlled release copolymer formulation with improved release kinetics | Jun 03, 09 | Nov 04, 14 | TOLMAR THERAPEUTICS, INC. |
| 8871712 | Somatostatin analogue formulations | Dec 09, 05 | Oct 28, 14 | CAMURUS AB |
| 8822442 | Somatostatin-dopamine chimeric analogs | Oct 28, 05 | Sep 02, 14 | IPSEN PHARMA S.A.S. |
| 8709998 | Peptide vectors | Apr 21, 04 | Apr 29, 14 | IPSEN PHARMA S.A.S. |
Recent Publications
Not Available
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 52 Months (last 2 years Issuances)
- 52 Months (last 5 years Issuances)